Burgundy Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-5,433
| Closed | -$237K | – | 105 |
|
2023
Q4 | $237K | Buy |
+5,433
| New | +$237K | ﹤0.01% | 104 |
|
2023
Q3 | – | Sell |
-5,206
| Closed | -$214K | – | 104 |
|
2023
Q2 | $214K | Hold |
5,206
| – | – | ﹤0.01% | 106 |
|
2023
Q1 | $299K | Hold |
5,206
| – | – | ﹤0.01% | 103 |
|
2022
Q4 | $292K | Hold |
5,206
| – | – | ﹤0.01% | 106 |
|
2022
Q3 | $221K | Hold |
5,206
| – | – | ﹤0.01% | 110 |
|
2022
Q2 | $281K | Hold |
5,206
| – | – | ﹤0.01% | 110 |
|
2022
Q1 | $335K | Hold |
5,206
| – | – | ﹤0.01% | 112 |
|
2021
Q4 | $349K | Hold |
5,206
| – | – | ﹤0.01% | 109 |
|
2021
Q3 | $357K | Hold |
5,206
| – | – | ﹤0.01% | 111 |
|
2021
Q2 | $355K | Hold |
5,206
| – | – | ﹤0.01% | 113 |
|
2021
Q1 | $360K | Hold |
5,206
| – | – | ﹤0.01% | 109 |
|
2020
Q4 | $338K | Hold |
5,206
| – | – | ﹤0.01% | 106 |
|
2020
Q3 | $246K | Hold |
5,206
| – | – | ﹤0.01% | 102 |
|
2020
Q2 | $245K | Hold |
5,206
| – | – | ﹤0.01% | 103 |
|
2020
Q1 | $233K | Buy |
+5,206
| New | +$233K | ﹤0.01% | 99 |
|